Novo Nordisk A/S (NVO)

Novo Nordisk A/S (NVO $47.64)
- $47.64 P/E (TTM): 13.41X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Eli Lilly and Company (LLY $1,058.18)
- $1,058.18 P/E (TTM): 54.16X Cap: $1T
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $47.64)
- $47.64 P/E (TTM): 13.41X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Hims & Hers Health Inc. Class A (HIMS $23.02)
- $23.02 P/E (TTM): 46.04X Cap: $5.55B
- View HIMS Profile
- View Questions on HIMS

Q: Greetings,

Is the sell off in NOVO Nordisk warranted? Seems a bit harsh me thinks.

Just when the stock was pulling out of a tax loss selling nose dive, it now seems to have run out of gas and is falling again.

1) Should we view such a steep drop as possibly an over reaction? Should we wait to see if a bottom forms before stepping in? Buy, sell or hold?

2) I know 5i favours Eli Lilly but has most of the growth already taken place or do you predict even higher altitudes? Buy now or wait for a dip?

Cheers
A

Read Answer Asked by Arzoo on February 06, 2026

Canadian National Railway Company (CNR $138.55)
- $138.55 P/E (TTM): 18.35X Cap: $84.70B
- View CNR Profile
- View Questions on CNR
Constellation Software Inc. (CSU $2,434.02)
- $2,434.02 P/E (TTM): 56.66X Cap: $51.58B
- View CSU Profile
- View Questions on CSU
- View Reports on CSU
Canadian Apartment Properties Real Estate Investment Trust (CAR.UN $38.19)
- $38.19 P/E (TTM): 101.08X Cap: $6B
- View CAR.UN Profile
- View Questions on CAR.UN
Descartes Systems Group Inc. (The) (DSG $91.25)
- $91.25 P/E (TTM): 38.9X Cap: $7.84B
- View DSG Profile
- View Questions on DSG
- View Reports on DSG
TMX Group Limited (X $45.42)
- $45.42 P/E (TTM): 28.49X Cap: $12.63B
- View X Profile
- View Questions on X
- View Reports on X
Thomson Reuters Corporation (TRI $120.18)
- $120.18 P/E (TTM): 23.62X Cap: $53.80B
- View TRI Profile
- View Questions on TRI
goeasy Ltd. (GSY $131.36)
- $131.36 P/E (TTM): 9.39X Cap: $2.06B
- View GSY Profile
- View Questions on GSY
- View Reports on GSY
KKR & Co. Inc. (KKR $103.20)
- $103.20 P/E (TTM): 44.39X Cap: $88.39B
- View KKR Profile
- View Questions on KKR
Novo Nordisk A/S (NVO $47.64)
- $47.64 P/E (TTM): 13.41X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Canadian General Investments Limited (CGI $47.75)
- $47.75 P/E (TTM): 25.51X Cap: $989M
- View CGI Profile
- View Questions on CGI
Apollo Global Management Inc. (APO $133.03)
- $133.03 P/E (TTM): 19.36X Cap: $73.17B
- View APO Profile
- View Questions on APO
Brookfield Renewable Partners L.P. Limited Partnership Units (BEP $30.47)
- $30.47 Cap: $19.99B
- View BEP Profile
- View Questions on BEP
Topicus.com Inc. (TOI $94.72)
- $94.72 P/E (TTM): 833.17X Cap: $7.88B
- View TOI Profile
- View Questions on TOI
- View Reports on TOI
Cellebrite DI Ltd. (CLBT $14.17)
- $14.17 Cap: $3.25B
- View CLBT Profile
- View Questions on CLBT
Propel Holdings Inc. (PRL $25.05)
- $25.05 P/E (TTM): 11.64X Cap: $985M
- View PRL Profile
- View Questions on PRL
- View Reports on PRL
Brookfield Corporation Class A Limited Voting Shares (BN $61.71)
- $61.71 P/E (TTM): 90.08X Cap: $138.55B
- View BN Profile
- View Questions on BN
Brookfield Asset Management Ltd. Class A Limited Voting Shares (BAM $67.75)
- $67.75 P/E (TTM): 30.88X Cap: $109.12B
- View BAM Profile
- View Questions on BAM
Lumine Group Inc. (LMN $20.00)
- $20.00 P/E (TTM): 77.81X Cap: $5.13B
- View LMN Profile
- View Questions on LMN
- View Reports on LMN
Intuitive Surgical CDR (CAD Hedged) (ISRG)
- P/E (TTM): 74.53X
- View ISRG Profile
- View Questions on ISRG
Blackstone CDR (CAD Hedged) (BX $16.43)
- $16.43 P/E (TTM): 37.17X Cap: $142.98B
- View BX Profile
- View Questions on BX

Q: Hi, Sorry there are lot of companies listed but in summary this is three part question:

1. I have BAM2%,BN9%,BEP5%. I was thinking of putting new money to KKR or BX or APO. Should i add new money to existing positions or to new positions. Which one and approx. price please.

2. All the listed are in red in various taxable and registered accounts. Which one is good candidate for new money , which one would be sell and hold.

3. ISRG is at 1.5%. Should i go to 5% in one shot or go slowly or just hold on . This is in taxable account.

Thanks

Read Answer Asked by S on February 05, 2026

Eli Lilly and Company (LLY $1,058.18)
- $1,058.18 P/E (TTM): 54.16X Cap: $1T
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $47.64)
- $47.64 P/E (TTM): 13.41X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: With the weight loss drugs now moving into pills, it seems like they will be even more popular. Do you have any suggestions of specific companies whose stock will benefit from this going forward. Or has this horse already left the barn.

Read Answer Asked by Maria on January 19, 2026